Novartis halts US production of radioligand cancer therapies, citing potential quality issues aliu Thu, 05/05/2022 – 12:20 More: Novartis halts US production of radioligand cancer therapies, citing potential quality issues Source: fierce
read moreIntercept sells Ocaliva rights outside the US after NASH development woes kdunleavy Thu, 05/05/2022 – 11:12 More: Intercept sells Ocaliva rights outside the US after NASH development woes Source: fierce
read moreMarinus restarts phase 3 seizure trials after stability, COVID delays jkeenan Thu, 05/05/2022 – 09:58 More: Marinus restarts phase 3 seizure trials after stability, COVID delays Source: fierce
read moreOn a roll, AstraZeneca’s Ultomiris hits goal in rare autoimmune disease aliu Thu, 05/05/2022 – 09:53 More: On a roll, AstraZeneca's Ultomiris hits goal in rare autoimmune disease Source: fierce
read moreAmid BeiGene’s global expansion push, CEO Oyler scores 16% pay raise to $16.7M kdunleavy Thu, 05/05/2022 – 09:11 More: Amid BeiGene's global expansion push, CEO Oyler scores 16% pay raise to .7M Source: fierce
read moreDELIVER represents the largest ever trial to address heart failure with preserved ejection fraction More: Farxiga demonstrates success in preserved ejection fraction trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals